- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prolymphocytic Leukemia in Canada
Total 575 results
-
BiogenTerminatedChronic Lymphocytic LeukemiaFrance, United States, Belgium, Australia, Austria, Poland, Canada, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedJuvenile Myelomonocytic LeukemiaUnited States, Canada, Australia, New Zealand
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
Bristol-Myers SquibbCompletedLeukemiaUnited States, Canada, Finland, Italy, United Kingdom, France, Germany
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia (CLL)United States, France, Italy, Poland, Canada, Israel, Germany, Belgium
-
CephalonCompletedAcute Myeloid LeukemiaUnited States, Canada, Australia, Germany, Israel, Italy, New Zealand, Poland, Romania, Russian Federation, Spain, Sweden, Ukraine
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Dynamic Science S.L.Active, not recruitingLeukemia, Myeloid, AcuteSpain, Portugal
-
AstraZenecaActive, not recruiting
-
Jazz PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Hematologic MalignancyUnited States, Canada
-
GlycoMimetics IncorporatedActive, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Spain, Australia, Netherlands, France, Ireland, Italy, United Kingdom
-
Astex Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States, Canada, Spain, Hungary, Austria, Czechia, France, Germany, Italy, United Kingdom
-
Jazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States, Canada
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
-
CelgeneTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, France, Canada, Norway, Spain, United Kingdom
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedMyelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Natural Killer Cell Lymphoblastic Leukemia/LymphomaUnited States, Australia, Canada
-
Hoffmann-La RocheCompletedNeoplasmsFrance, Canada, Netherlands, Korea, Republic of, Australia
-
Astex Pharmaceuticals, Inc.CompletedLeukemia, Myeloid, AcuteUnited States, Spain, Korea, Republic of, Taiwan, Australia, Canada, Denmark, Hungary, Japan, Finland, Italy, Serbia, Czechia, France, Germany, Sweden, Netherlands, Poland, Russian Federation, Austria, United Kingdom, Romania, Belgium, Bulgar...
-
Maxim PharmaceuticalsCompletedLeukemiaUnited States, France, Israel, Australia, Canada, Sweden, Finland, Germany, New Zealand, Denmark, Estonia, United Kingdom
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States, Canada
-
Seattle Children's HospitalChildren's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...CompletedAML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDSUnited States, Canada
-
Astex Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States, Canada, Belgium, Spain, Germany, Denmark, Korea, Republic of, Hungary, France, Japan, Italy, Poland, Sweden, Ukraine, United Kingdom
-
Novartis PharmaceuticalsRecruitingAcute Myeloid LeukemiaSpain, Germany, Italy, France
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
NCIC Clinical Trials GroupS*BIOCompletedLeukemia | Solid TumoursCanada
-
Jazz PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada
-
Jazz PharmaceuticalsThe Leukemia and Lymphoma SocietyCompletedAcute Myeloid LeukemiaUnited States, Poland, Canada, France
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities and other conditionsUnited States, Canada, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States, Canada
-
Boehringer IngelheimCompletedLeukemia, Myeloid, AcuteKorea, Republic of, Spain, Canada, Germany, Norway, Taiwan, Belgium, United States, Japan, Mexico, France, Greece, Italy, India, Austria, Portugal, Czechia, Russian Federation, Hungary, Brazil, Argentina, Finland, Netherlands, Poland, South...
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Therapeutic Advances in Childhood Leukemia ConsortiumSpectrum Pharmaceuticals, IncRecruitingLymphoblastic Leukemia, Acute, Childhood | ALL, Childhood | Lymphoblastic Leukemia, AcuteUnited States, Australia, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada
-
Gilead SciencesTerminatedAcute Myeloid LeukemiaUnited States, Spain, Belgium, United Kingdom, Germany, Australia, Hong Kong, Denmark, France, Japan, Canada, Italy, Austria, Sweden, Switzerland
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, Chronic PhaseUnited States, Argentina, Italy, Canada, Australia, Brazil
-
Merck Sharp & Dohme LLCRecruitingNon-Hodgkins Lymphoma | Hematologic Malignancies | Chronic Lymphocytic Leukaemia | Waldenstroms MacroglobulinaemiaPoland, United States, Argentina, Australia, Brazil, Canada, France, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom, Korea, Republic of, Germany, Denmark, China, Romania, Czechia, Hungary, Ireland, Ukraine
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaChina, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Lymphoblastic LeukemiaUnited States, Australia, Canada, Brazil
-
Shattuck Labs, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States, Canada, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Lymphoblastic Leukemia in Remission | Graft Versus Host Disease | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia
-
AmgenRecruitingB Cell Precursor Acute Lymphoblastic LeukemiaJapan, Australia, Spain, United States, Italy, Germany, France, Turkey, Canada, Netherlands, Austria
-
Vor BiopharmaRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Canada
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Facet BiotechNational Cancer Institute (NCI)UnknownLeukemiaUnited States, Canada, Netherlands, Belgium, Germany, United Kingdom, France
-
AstraZenecaRecruitingB-cell Acute Lymphoblastic Leukemia (B-ALL)Spain, Canada, United Kingdom, Italy, Germany, Australia, United States, Taiwan, France, Korea, Republic of, China
-
AbbVieRoche-GenentechActive, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom